Ultimately, the stimulatory effects of TGF-β on its production by CAFs and TAMs make TGF-β–targeted therapies an appealing strategy for restoring immune function and obstructing ovarian cancer growth; however, the application of TGF-β depletion to simultaneously modulate CAFs and TAMs is an area requiring further study. Here, TGFB1 is linked to ovarian carcinoma.